However, Huang Huangshun’s remarks just highlight the difficulty of implementing

[Mst.Rina1R]

The single-track system. Zhou Qingming emphasized that Taiwan has long had a clear specialty system. In single departments such as otolaryngology, pediatrics, and gastroenterology, there are hundreds of commonly used drugs. In addition to doctors being responsible for diagnosis, clinic pharmacists can also rely on their professionalism to inform the public when dispensing. Explain, "But can all community pharmacies prepare medicines for various specialties? Are pharmacists in every pharmacy omnipotent?" This is a question that cannot be ignored.

There are still many differences of opinion in this pharmaceutical war, but whether clinic pharmaceutical service fees will be increased will surely be answered at the National Health Insurance Total Negotiation Meeting on September 25. As time approaches, Director of National Health Insurance Shi Chongliang said that he has held consultations with the pharmaceutical honduras telegram industry at the end of August and will discuss it again with the All-Federation of Physicians in mid-September. He hopes that under the three principles of medical separation, hierarchical medical care, and protecting people's rights and interests, Build consensus with both parties to promote the accessibility of medicines to the public.

Wang Hongyu lamented that this initiative to increase clinic pharmaceutical service fees also has an important significance in protecting rural clinics. Clinic pharmacists have low health insurance benefits and poor remuneration, and there are few community pharmacies willing to set up shop in remote rural areas. Once the senior pharmacists retire and resign, it will be difficult for the clinic to operate, and medical resources in rural areas will become even scarcer, which may not be what the government would like to see.

Regardless of how medicine is divided, whether clinics employ their own pharmacists or cooperate with community pharmacies, the government should ensure that every patient can receive medicine and be treated. Putting patients at the center and protecting patients' rights to use drugs should also be the top priority when the medical and pharmaceutical communities propose initiatives and the government promotes reforms.